Akoya Biosciences Inc (AKYA) — Strategic Asset Allocation Index
Akoya Biosciences Inc (AKYA) has a Strategic Asset Allocation Index of 24.9% as of September 2024. Strategic assets (PP&E of $- plus long-term investments of $3.40 Million) total $3.40 Million, measured against net assets of $13.63 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Akoya Biosciences Inc balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Akoya Biosciences Inc Strategic Asset Allocation Index (2020–2022)
This chart shows how Akoya Biosciences Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of September 2024, the index stands at 24.9%, representing strategic assets of $3.40 Million against net assets of $13.63 Million USD. For live market cap and overall valuation, see Akoya Biosciences Inc (AKYA) market capitalisation.
Annual Strategic Asset Allocation Index for Akoya Biosciences Inc (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Akoya Biosciences Inc from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See what is Akoya Biosciences Inc's book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 17.4% | $10.17 Million | $10.17 Million | $- | $58.58 Million | ▲ +11.2 pp |
| 2021 | 6.2% | $7.49 Million | $7.49 Million | $- | $121.35 Million | ▼ -23.6 pp |
| 2020 | 29.8% | $5.53 Million | $5.53 Million | $- | $18.57 Million | — |